Serological IgG avidity test for ocular toxoplasmosis by Suresh, Subramaniam et al.
© 2012 Suresh et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Ophthalmology 2012:6 147–150
Clinical Ophthalmology
Serological IgG avidity test for ocular 
toxoplasmosis
Subramaniam Suresh1
Saidin Nor-Masniwati1
Muhd Nor Nor-Idahriani1
Wan-Hitam Wan-Hazabbah1
Mohamed Zeehaida2
Embong Zunaina1
1Department of Ophthalmology, 
2Department of Medical Microbiology 
and Parasitology, School of Medical 
Sciences, Universiti Sains Malaysia, 
Kelantan, Malaysia
Correspondence: Embong Zunaina 
Department of Ophthalmology, School 
of Medical Sciences, Universiti Sains 
Malaysia, 16150 Kubang Kerian,  
Kelantan, Malaysia 
Tel +609 767 6361 
Fax +609 765 3370 
Email zunaina@kb.usm.my
Background: The purpose of this study was to evaluate the immunoglobulin (Ig) G avidity 
of serological toxoplasmosis testing in patients with ocular inflammation and to determine the 
clinical manifestations of ocular toxoplasmosis.
Methods: A retrospective review of all patients presenting with ocular inflammation to the 
Hospital Universiti Sains Malaysia, Kelantan, Malaysia between 2005 and 2009 was undertaken. 
Visual acuity, clinical manifestations at presentation, toxoplasmosis antibody testing, and 
  treatment records were analyzed.
Results: A total of 130 patients with ocular inflammation were reviewed retrospectively. The 
patients had a mean age of 38.41 (standard deviation 19.24, range 6–83) years. Seventy-one 
patients (54.6%) were found to be seropositive, of whom five (3.8%) were both IgG and IgM 
positive (suggestive of recently acquired ocular toxoplasmosis) while one (0.8%) showed IgG 
avidity #40% (suggestive of recently acquired ocular toxoplasmosis) and 65 patients (50.0%) 
showed IgG avidity .40% (suggestive of reactivation of toxoplasmosis infection). Chorioretinal 
scarring as an ocular manifestation was significantly more common in patients with seropositive 
toxoplasmosis (P = 0.036). Eighteen patients (13.8%) were diagnosed as having recent and/or 
active ocular toxoplasmosis based on clinical manifestations and serological testing.
Conclusion: Ocular toxoplasmosis is a clinical diagnosis, but specific toxoplasmosis antibody 
testing helps to support the diagnosis and to differentiate between reactivation of infection and 
recently acquired ocular toxoplasmosis.
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Introduction
Ocular toxoplasmosis is the most common cause of posterior uveitis in immunocom-
petent individuals.1 Recognizing the presence of Toxoplasma gondii in the infected 
eye is difficult and rarely possible unless further investigation is done on aspirated 
aqueous or subretinal fluid from either an intact or enucleated eye. Despite the 
  availability of various diagnostic methods, ocular toxoplasmosis is often based on 
clinical manifestations.2,3
Ocular toxoplasmosis has a variety of clinical signs and symptoms with various 
levels of ocular inflammation.4,5 The most common feature is focal retinitis or 
chorioretinitis, where it can manifest as either localized necrotizing retinitis with 
inflammation of subjacent choroid or an active creamy-white focal retinal lesion.6 
In Malaysia, the seroprevalence of T. gondii is estimated to be around 37.0% for 
antitoxoplasmosis antibodies.7 Serological testing for specific antibodies has been used 
as laboratory evidence of the disease, but titration of these antibodies has low reliability 
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in ocular toxoplasmosis. Toxoplasma immunoglobulin (Ig) G 
avidity testing is a qualitative method to improve serological 
diagnosis of the acute infection with a low avidity index. Low 
IgG avidity does not always identify a case of recent ocular 
toxoplasmosis, but a high IgG avidity result can exclude a 
primary infection acquired during the previous 5 months.8 
Thus, it is a powerful tool for distinguishing between recent 
and distant T. gondii infection.9 In ocular toxoplasmosis, 
this IgG avidity assay is helpful for differentiation between 
reactivation of infection (high IgG avidity) and recently 
acquired (low IgG avidity) ocular toxoplasmosis in 
immunocompetent patients.8 The purpose of this study was 
to evaluate IgG avidity of serological toxoplasmosis testing 
in cases of ocular toxoplasmosis and to determine the clinical 
manifestations of the disease.
Materials and methods
A total of 130 medical records for ocular inflammation 
cases presenting to the Hospital Universiti Sains Malaysia 
between 2005 and 2009 were traced. Clinical records were 
reviewed and data were recorded for each patient, includ-
ing visual acuity, ocular manifestations at presentation, the 
serum toxoplasmosis antibody assay result, and treatment 
given.
An enzyme-linked immunosorbent assay method was 
used to determine the toxoplasmosis IgG antibody and 
IgM antibody status for each patient. IgG avidity status 
was determined using commercial Platelia Toxo IgM, IgG, 
and IgG avidity kits (BioRad, France). IgM and IgG use 
a qualitative assay, while IgG avidity provides additional 
information on percentage avidity. The percentage avidity 
for each positive IgG is calculated according to the 
manufacturer’s instructions. An IgG avidity .40% indicates 
past infection while IgG avidity #40% indicates recent 
toxoplasmosis infection of ,20 weeks.
SPSS software version 12 (SPSS Inc, Chicago, IL) was 
used for the statistical analysis. A descriptive univariate 
analysis was performed to evaluate frequency of the variables 
and T. gondii antibodies. Possible associations were identified 
using Chi-squared tests at a significance level of 5%.
Results
A total of 130 patients with ocular inflammation were 
reviewed retrospectively. The patients had a mean age of 
38.41 (standard deviation 19.24, range 6–83) years. All 
patients recruited for this retrospective case series were 
immunocompetent. The gender and ethnicity distribution is 
shown in Table 1.
Of the 130 patients, 71 (54.6%) were found to be 
  seropositive, of whom 66 (50.8%) were IgG positive 
only and five (3.8%) were positive for both IgG and IgM. 
  Sixty-five patients (50.0%) were noted to have high IgG 
avidity (.40%) and only one (0.8%) showed low IgG   avidity 
(#40%, Table 2).
Eighteen patients were diagnosed to have ocular 
  toxoplasmosis according to clinical manifestations, and 
were found to be seropositive (Table 3). Serological testing 
for ocular toxoplasmosis had a sensitivity of 100% and a 
specificity of 53% to detect ocular toxoplasmosis with ocular 
inflammation. The positive predictive value was 25.4% and 
the negative predictive value was 100%.
Of the 71 patients with seropositive toxoplasmosis, six 
had results suggestive of recently acquired ocular toxoplas-
mosis of ,20 weeks (five patients were positive for both IgM 
and IgG and one patient showed IgG avidity #40%). In the 
other 65 patients with seropositive toxoplasmosis, ocular 
inflammation was suggestive of reactivation of toxoplasmosis 
infection (IgG avidity .40%). We did not analyze the data 
to identify other causes of ocular inflammation in patients 
with seronegative toxoplasmosis.
Thirty-two  patients  (45.1%)  with  seropositive 
toxoplasmosis presented with visual acuity better than 
6/36, while 28 patients (39.4%) had vision worse than 6/60 
(Figure 1). Presenting ocular manifestations in patients with 
seropositive and seronegative toxoplasmosis are shown in 
Table 2 Serological toxoplasmosis test for ocular inflammation
Serological toxoplasmosis test n = 130  
n (%) IgM IgG
Positive Positive 5 (3.8%)
Positive Negative 0 (0.0%)
Negative Positive avidity #40% 1 (0.8%)
Negative Positive avidity .40% 65 (50.0%)
Negative Negative 59 (45.4%)
Table 1 Age and gender distribution of 130 patients with ocular 
inflammation
Variable n = 130
Gender
  Male 72 (55.4%)
  Female 58 (44.6%)
Age (years)
  Mean (standard deviation) 38.41 ± 19.24
  Median (range) 37 (6–83)
race/ethnicity
  Malay 117 (90%)
  Non-Malay 13 (10%)
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Table 4. Chorioretinal scarring was the ocular manifestation 
present significantly more often in patients with seropositive 
toxoplasmosis (P = 0.036), while an anterior chamber 
reaction was present significantly more often in patients 
with seronegative toxoplasmosis (P = 0.046).
Based on clinical manifestation and serological   testing, 
18 (13.8%) patients were diagnosed to have recent 
and/or active ocular toxoplasmosis infection. However, 
only 12 (66.7%) were treated with antitoxoplasmosis drugs 
(Figure 2). In another six patients (33.3%), no antitoxoplas-
mosis drug was given because the inflammation had already 
resolved spontaneously by the time of initiation of treatment. 
Ocular inflammation resolved with topical steroids in other 
patients with seropositive toxoplasmosis. We did not inves-
tigate for a relationship between IgG avidity and treatment 
options for seropositive toxoplasmosis.
Discussion
Of 130 patients who presented with ocular inflammation, 
71 (54.6%) had IgG antibodies to T. gondii. This indicates 
that active or dormant toxoplasmosis is not a rare entity in the 
Kelantan population in Malaysia. Most of our patients with 
ocular toxoplasmosis presented before the age of 40 years, 
which is consistent with the report of Dodds et al of patients 
presenting before the age of 35 years.10
Of  the  130  patients  with  ocular  inflammation, 
117   presented with blurring of vision and 52.1% were 
seropositive for   toxoplasmosis. Of these, the majority 
(45.1%) presented with vision better than 6/36, and 39.4% 
presented with vision worse than 6/60. Poor vision is one of 
the common ocular manifestations at presentation in patients 
with ocular   toxoplasmosis.11
Ocular inflammation is the main feature indicating the 
possibility of ocular toxoplasmosis. The presence of chori-
oretinal scarring raises suspicion of ocular   toxoplasmosis.4 
In this study, 26 patients presented with chorioretinal 
scarring, about 76.9% of whom had a seropositive test 
result. Garweg et al undertook a clinical analysis of ocular 
  toxoplasmosis and found that in patients with a clinical diag-
nosis of ocular toxoplasmosis, laboratory tests were positive 
in around 60%–90% of cases.12
Consistent with this study, all our 18 patients with a clini-
cal diagnosis of ocular toxoplasmosis were IgG positive but 
had different levels of avidity. Introduction of the IgG avidity 
assay aids diagnosis of toxoplasmosis and helps the clini-
cian to differentiate between reactivation of infection (high 
IgG avidity) and recently acquired (low IgG avidity) ocular 
toxoplasmosis in immunocompetent patients. However, 
detection of local antibody production from the aqueous or 
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Figure 1 Visual acuity of affected eye at presentation.
Abbreviations: CF, counting finger; PL, perception of light; NPL, non-perception 
of light.
Table 3 Serological test to detect ocular toxoplasmosis in ocular 
inflammation
Serological  
toxoplasmosis test
Clinical diagnosis of ocular 
toxoplasmosis
Yes No
Seropositive 18 53
Seronegative 0 59
Table 4 Ocular manifestations at presentation in patients with 
ocular inflammation
Clinical manifestation Toxoplasmosis  
serology, n (%)
P value*
Positive Negative
Blurring of vision 61 (52.1%) 56 (47.9%) 0.089
redness 26 (20.0%) 29 (22.3%) 0.150
Eye pain 23 (50.0%) 23 (50.0%) 0.434
Headache 6 (37.5%) 10 (62.5%) 0.142
Vomiting 1 (50.0%) 1 (50.0%) 1.000
Floaters 10 (52.6%) 9 (47.4%) 0.851
Anterior chamber reaction 27 (45.0%) 33 (55.0%) 0.046
Vitritis 19 (48.7%) 20 (51.3%) 0.335
Vasculitis 4 (50.0%) 4 (50.0%) 1.000
Choroiditis 9 (52.9%) 8 (47.1%) 0.893
retinitis 7 (53.8%) 6 (46.2%) 0.908
Chorioretinal scar 20 (76.9%) 6 (23.1%) 0.036
Note: *Chi-square test significant at P , 0.05.
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Figure 2 Distribution of patients received anti toxoplasmosis treatment in active 
ocular toxoplasmosis.
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vitreous humor appears to be more useful in   diagnosing   ocular 
toxoplasmosis. We did not undertake antibody   detection from 
the aqueous or vitreous humor in our study.
Conclusion
Ocular toxoplasmosis is a clinical diagnosis. Antitoxoplasmosis 
antibody testing helps to establish the diagnosis and to dif-
ferentiate between reactivation of infection and recently 
acquired ocular toxoplasmosis.
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